150 related articles for article (PubMed ID: 30877795)
1. Testing for SGT-151 (CUMYL-PEGACLONE) and its Metabolites in Blood and Urine after Surreptitious Administration.
Aknouche F; Ameline A; Richeval C; Schapira AJ; Coulon A; Maruejouls C; Gaulier JM; Kintz P
J Anal Toxicol; 2020 Jan; 44(1):75-80. PubMed ID: 30877795
[TBL] [Abstract][Full Text] [Related]
2. Identification of a thermal degradation product of CUMYL-PEGACLONE and its detection in biological samples.
Nash C; Glowacki L; Gerostamoulos D; Pigou P; Scott T; Kostakis C
Drug Test Anal; 2019 Oct; 11(10):1480-1485. PubMed ID: 31479592
[TBL] [Abstract][Full Text] [Related]
3. Phase I metabolism of the recently emerged synthetic cannabinoid CUMYL-PEGACLONE and detection in human urine samples.
Mogler L; Wilde M; Huppertz LM; Weinfurtner G; Franz F; Auwärter V
Drug Test Anal; 2018 May; 10(5):886-891. PubMed ID: 29314750
[TBL] [Abstract][Full Text] [Related]
4. Detection and phase I metabolism of the 7-azaindole-derived synthetic cannabinoid 5F-AB-P7AICA including a preliminary pharmacokinetic evaluation.
Giorgetti A; Mogler L; Haschimi B; Halter S; Franz F; Westphal F; Fischmann S; Riedel J; Pütz M; Auwärter V
Drug Test Anal; 2020 Jan; 12(1):78-91. PubMed ID: 31476105
[TBL] [Abstract][Full Text] [Related]
5. Detection of metabolites of the new synthetic cannabinoid CUMYL-4CN-BINACA in authentic urine samples and human liver microsomes using high-resolution mass spectrometry.
Öztürk YE; Yeter O; Öztürk S; Karakus G; Ates I; Buyuk Y; Yurdun T
Drug Test Anal; 2018 Mar; 10(3):449-459. PubMed ID: 28691766
[TBL] [Abstract][Full Text] [Related]
6. Human phase I metabolism of the novel synthetic cannabinoid 5F-CUMYL-PEGACLONE.
Mogler L; Halter S; Wilde M; Franz F; Auwärter V
Forensic Toxicol; 2019; 37(1):154-163. PubMed ID: 30636984
[TBL] [Abstract][Full Text] [Related]
7. Detection of Synthetic Cannabinoid CUMYL-PEGACLONE in E-Cigarette Oil and Hair.
Jiao TF; Li YQ; Kang G; Chen SS; Cheng LH
Fa Yi Xue Za Zhi; 2022 Oct; 38(5):595-600. PubMed ID: 36727175
[TBL] [Abstract][Full Text] [Related]
8. Biotransformation of the New Synthetic Cannabinoid with an Alkene, MDMB-4en-PINACA, by Human Hepatocytes, Human Liver Microsomes, and Human Urine and Blood.
Watanabe S; Vikingsson S; Åstrand A; Gréen H; Kronstrand R
AAPS J; 2019 Dec; 22(1):13. PubMed ID: 31848852
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines, and cannabinoids in human whole blood by liquid chromatography-tandem mass spectrometry - A New Zealand perspective of use in 2018.
Ong RS; Kappatos DC; Russell SGG; Poulsen HA; Banister SD; Gerona RR; Glass M; Johnson CS; McCarthy MJ
Drug Test Anal; 2020 Feb; 12(2):195-214. PubMed ID: 31595682
[TBL] [Abstract][Full Text] [Related]
10. Emergence of Cumyl-PEGACLONE-related fatalities in the Northern Territory of Australia.
Tiemensma M; Rutherford JD; Scott T; Karch S
Forensic Sci Med Pathol; 2021 Mar; 17(1):3-9. PubMed ID: 33185835
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Phase I Metabolism of the Recently Emerged Synthetic MDMB-4en-PINACA and Its Detection in Human Urine Samples.
Erol Ozturk Y; Yeter O
J Anal Toxicol; 2021 Jan; 44(9):976-984. PubMed ID: 32091101
[TBL] [Abstract][Full Text] [Related]
12. Detection and characterization of the new synthetic cannabinoid APP-BINACA in forensic casework.
Krotulski AJ; Mohr ALA; Diamond FX; Logan BK
Drug Test Anal; 2020 Jan; 12(1):136-144. PubMed ID: 31788963
[TBL] [Abstract][Full Text] [Related]
13. Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in "legal high" products and human urine specimens.
Haschimi B; Mogler L; Halter S; Giorgetti A; Schwarze B; Westphal F; Fischmann S; Auwärter V
Drug Test Anal; 2019 Sep; 11(9):1377-1386. PubMed ID: 31228224
[TBL] [Abstract][Full Text] [Related]
14. Occupational transdermal poisoning with synthetic cannabinoid cumyl-PINACA.
Dobaja M; Grenc D; Kozelj G; Brvar M
Clin Toxicol (Phila); 2017 Mar; 55(3):193-195. PubMed ID: 28084855
[TBL] [Abstract][Full Text] [Related]
15. Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls.
Möller I; Wintermeyer A; Bender K; Jübner M; Thomas A; Krug O; Schänzer W; Thevis M
Drug Test Anal; 2011 Sep; 3(9):609-20. PubMed ID: 20872894
[TBL] [Abstract][Full Text] [Related]
16. Identification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry.
Vikingsson S; Gréen H; Brinkhagen L; Mukhtar S; Josefsson M
Drug Test Anal; 2016 Sep; 8(9):950-6. PubMed ID: 26560240
[TBL] [Abstract][Full Text] [Related]
17. Quantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimens.
Castaneto MS; Scheidweiler KB; Gandhi A; Wohlfarth A; Klette KL; Martin TM; Huestis MA
Drug Test Anal; 2015 Jun; 7(6):483-93. PubMed ID: 25231213
[TBL] [Abstract][Full Text] [Related]
18. Phase I metabolism of the carbazole-derived synthetic cannabinoids EG-018, EG-2201, and MDMB-CHMCZCA and detection in human urine samples.
Mogler L; Franz F; Wilde M; Huppertz LM; Halter S; Angerer V; Moosmann B; Auwärter V
Drug Test Anal; 2018 Sep; 10(9):1417-1429. PubMed ID: 29726116
[TBL] [Abstract][Full Text] [Related]
19. Detection of main metabolites of XLR-11 and its thermal degradation product in human hepatoma HepaRG cells and human urine.
Kanamori T; Kanda K; Yamamuro T; Kuwayama K; Tsujikawa K; Iwata YT; Inoue H
Drug Test Anal; 2015 Apr; 7(4):341-5. PubMed ID: 25600155
[TBL] [Abstract][Full Text] [Related]
20. Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS/MS and library search.
Wohlfarth A; Scheidweiler KB; Chen X; Liu HF; Huestis MA
Anal Chem; 2013 Apr; 85(7):3730-8. PubMed ID: 23458260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
